t wasn’t your usual earnings call.

Dr. Patrick Soon-Shiong opened a routine report on his company NantHealth’s first quarter results with this: “Before I go into the details about our business, I would like to take this opportunity to get something off my chest.”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • there she blows again – Rebecca the Harvard grad with an axe to grind. if you really want to cover Soon Shiong, why not cover ALL the news, including FDA approvals for the combination immunotherapy protocols that will be informed by GPS Cancer? oh, that’s right Rebecca doesn’t do reporting, only bashing. Soon Shiong is bent on saving lives, and RR is bent on slowing him down so big pharma can catch up. got to protect that swamp, right RR?

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.